Categories
News

By Registering a CAGR of 7.4%, Lymphedema Diagnostics Market is Anticipated to Reach USD 35 Million By 2024

The global lymphedema diagnostics market is projected to reach USD 35 million by 2024 from USD 24 million in 2019, at a CAGR of 7.4%. The major factors driving the growth of this market include the increasing global prevalence of cancer and lymphedema; technological advancements in diagnostic imaging modalities; and increasing investments, funds, and grants by public-private organizations. However, the high cost of diagnostic imaging systems, the short half-life of radiopharmaceuticals, and the limited supply of helium are expected to hinder the growth of this market. CLICK HERE FOR SAMPLE COPY

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

“The lymphoscintigraphy segment accounted for the largest market share in 2018.”

Based on technology, the lymphedema diagnostics market is segmented into lymphoscintigraphy, magnetic resonance imaging (MRI), ultrasound imaging, computed tomography (CT), X-ray lymphography, bioimpedance analysis, and near-infrared fluorescence imaging. The lymphoscintigraphy segment accounted for the largest share of the lymphedema diagnostics market in 2018. The noninvasive nature and easy reproducibility of this technology, and the fact that lymphoscintigraphy does not adversely affect the lymphatic vascular endothelium are some of the key advantages supporting the adoption of this technology.

“The cancer segment accounted for the largest share of the lymphedema diagnostics market in 2018.”

On the basis of disease type, the lymphedema diagnostics market is segmented into cancer, inflammatory diseases, cardiovascular disease, and other diseases (congenital abnormalities, trauma-related conditions, infections, and filariasis). The cancer segment accounted for the largest share of the lymphedema diagnostics market in 2018. The large share of this segment can be attributed to the rising prevalence of cancer-associated lymphedema and increasing awareness about early disease diagnosis.

“Europe to account for the second-largest share of the global market in 2019.”

The lymphedema diagnostics market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. Europe is expected to account for the second-largest share of the global lymphedema diagnostics market in 2019. The rising incidence of chronic diseases and injuries, growing demand for early diagnosis and treatment, technological advancements, product launches, and increasing government and public-private investments for developing novel diagnostic imaging modalities are the major factors driving market growth in Europe.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 (25%), Tier 2 (30%), and Tier 3 (42%)
• By Designation: C-level (26%), Director-level (30%), and Others (44%)
• By Region: North America (34%), Europe (26%), APAC (23%), and RoW (17%)

Updated Research Report @sdki.jp With Impact Analysis of COVID-19

Special Mission Aircraft Market
Phase Change Material Market
IoT in Aviation Market
Electric Ships Market

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

The major players in the market include GE Healthcare (US), Philips (Netherlands), Siemens Healthineers (Germany), Canon, Inc. (Japan), Shimadzu Corporation (Japan), Stryker Corporation (US), Fluoptics (France), United Imaging Healthcare Co., Ltd. (China), Hitachi, Ltd. (Japan), Esaote, SpA (Italy), Neusoft Corporation (China), Mindray Medical International, Ltd. (China), Mitaka USA, Inc. (US), Curadel, LLC (US), and ImpediMed Ltd. (Australia).

Research Coverage

This report studies the lymphedema diagnostics market based on technology, disease type, end user, and region. The report also studies factors (such as drivers and restraints) affecting market growth. In addition, it analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions (and the respective countries in these regions).

Key Benefits of Buying the Report

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, opportunities, and challenges.

Request to fill the form To Get a Sample Copy of This Report: https://www.sdki.jp/sample-request-61930

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY 18
1.5 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY DATA 21
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY DATA 22
2.1.2.1 Key data from primary sources 23
2.2 MARKET SIZE ESTIMATION 24
2.2.1 PRODUCT-BASED MARKET ESTIMATION 25
2.2.2 PRIMARY RESEARCH VALIDATION 26
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 27
2.4 RESEARCH LIMITATIONS AND ASSUMPTIONS 28
2.4.1 LIMITATIONS 28
2.4.2 ASSUMPTIONS 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 33
4.1 LYMPHEDEMA DIAGNOSTICS: MARKET OVERVIEW 33
4.2 REGIONAL ANALYSIS: LYMPHEDEMA DIAGNOSTICS MARKET, BY DISEASE TYPE (2019) 34
4.3 LYMPHEDEMA DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019 VS. 2024 (USD MILLION) 35
4.4 NEAR-INFRARED FLUORESCENCE IMAGING MARKET, BY TYPE,
2019 VS. 2024 (USD MILLION) 36
4.5 LYMPHEDEMA DIAGNOSTICS MARKET, BY COUNTRY 37  <<<<CONT>>>>

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:

Shibuya Data Count
Email: [email protected]
Tel: + 81 3 45720790

Categories
News

Cold Plasma Market Analysis 2020-2024 by End-Users, Applications, Latest Technology, Leading Companies, Future Growth, SWOT Analysis

The global cold plasma market size is expected to reach USD 3.1 billion by 2024 from USD 1.5 billion in 2019, at a CAGR of 15.6% during the forecast period. The growth in this market is primarily attributed to the benefits of cold plasma, such as its environment-friendliness, innovations in textile production, growing food safety concerns, innovations in cold plasma technology, and the increasing use of cold plasma in meat and poultry packaging decontamination.

Request to fill the form To Get a Sample Copy of This Report: https://www.sdki.jp/sample-request-61935

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

By polymer & plastic industry, the surface treatment segment accounted for the largest market share of the market

Within the polymer & plastic industry, the cold plasma market has been segmented into surface treatment, printability, adhesion, and other applications. The surface treatment segment accounted for the largest share of the cold plasma industry in 2019. Advantages of cold plasma treatment, such as enabling surfaces to be contamination-free from dirt, grease, oils, and fluorine, which allows for better wetting, initial adhesion, and long-term stability drive the growth of this segment.

Atmospheric cold plasma for the polymer & plastic industry is expected to grow at the highest CAGR during the forecast period
Based on the regime for the polymer & plastic industry, the cold plasma market has been segmented into atmospheric cold plasma and low-pressure cold plasma. The atmospheric cold plasma segment is expected to witness the highest CAGR owing to the profitable, fast, and environment-friendly option.

“APAC is projected to witness the highest growth during the forecast period.”

Europe is expected to account for the largest share of the global cold plasma market in 2019. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period due to rising manufacturing activities in Asian countries (particularly electronics, textiles, and polymers) and the increasing demand for decontaminated frozen food.

The breakdown of primary participants was as mentioned below:
• By Company Type: Tier 1–35%, Tier 2–40%, and Tier 3–25%
• By Designation: C-level–35%, Director Level–25%, and Others–40%
• By Region: North America–35%, Europe–30%, Asia Pacific–15%, Latin America–10%, Middle East & Africa – 10%

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

Updated Research Report @sdki.jp With Impact Analysis of COVID-19

Digital MRO Market
5G in Defense Market
Weather Forecasting Services Market
Military Robots Market

Research Coverage:

The report analyzes the various cold plasma products and their adoption patterns in different industries such as textile, electronics & semiconductors, polymer & plastic, food & agriculture, and medical. It aims at estimating the market size and future growth potential of the global cold plasma market for different segments such as industries, and their applications, regime, and regions. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global cold plasma market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the global cold plasma market
• Market Development: Comprehensive information on the lucrative emerging regions by industry, regime, and region
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global cold plasma market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global cold plasma market

Request to fill the form To Get a Sample Copy of This Report: https://www.sdki.jp/sample-request-61935

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

TABLE OF CONTENTS

1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 MARKET SCOPE 21
1.3.1 MARKETS COVERED 22
1.3.2 YEARS CONSIDERED FOR THE STUDY 22
1.4 CURRENCY 23
1.5 LIMITATIONS 23
1.6 STAKEHOLDERS 23
2 RESEARCH METHODOLOGY 24
2.1 RESEARCH DATA 24
2.1.1 SECONDARY DATA 24
2.1.1.1 Key data from secondary sources 25
2.1.2 PRIMARY DATA 25
2.1.2.1 Key data from primary sources 26
2.1.2.2 Breakdown of primary sources 27
2.2 MARKET SIZE ESTIMATION 27
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 29
2.4 MARKET SHARE ESTIMATION 30
2.5 ASSUMPTIONS FOR THE STUDY 30
3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 36
4.1 COLD PLASMA MARKET OVERVIEW 36
4.2 EUROPE: COLD PLASMA MARKET FOR THE TEXTILE INDUSTRY, BY APPLICATION 37
4.3 COLD PLASMA MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 38
4.4 COLD PLASMA MARKET, BY REGION (2017–2024) 39   <<<CONT>>>>

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:

Shibuya Data Count
Email: [email protected]
Tel: + 81 3 45720790

Categories
News

Cell Analysis Market Is Expected To Driven By Funding for Cell-Based Research and Rising Incidence of Chronic and Infectious Diseases (Registering CAGR of 7.2% Till 2024)

“Funding for cell-based research and rising incidence of chronic and infectious diseases are expected to drive the overall growth of the cell analysis market.” The cell analysis market is expected to reach USD 22.7 billion by 2024 from USD 16.0 billion in 2019, at a CAGR of 7.2% during the forecast period. This market is experiencing significant growth due to factors such as increasing government funding for cell-based research and the rising incidence of chronic and infectious diseases. However, the high installation and implementation costs of cell analysis systems and inadequate infrastructure and R&D funding in emerging economies may hinder the pace of market growth.

CLICK HERE FOR SAMPLE COPY OF THIS REPORT

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

“The cell identification segment is expected to dominate the market during the forecast period.”

Based on process, the global cell analysis market is segmented into cell identification, cell viability, cell signaling pathway/signal transduction, cell proliferation, cell counting & quality control, cell interaction, cell structure study, target identification & validation, and single-cell analysis. In 2018, the cell identification segment commanded the largest share of the global cell analysis market. This is primarily attributed to the high usage of this process to identify cancerous cells and common food-borne diseases.

“Pharmaceutical & biotechnology companies and CROs to witness the highest growth in the cell analysis market.”

Based on end users, the cell analysis market is segmented into hospitals & diagnostic laboratories, research institutes, pharmaceutical & biotechnology companies and CROs, cell culture collection repositories, and other end users. The pharmaceutical & biotechnology companies and CROs segment is expected to register the highest CAGR during the forecast period. These facilities use cell analysis instruments and consumables during various stages of drug discovery, drug research and development, pharmacokinetics, toxicology, and clinical studies. Growing regulatory approvals for cell culture-based vaccines, increasing pharmaceutical R&D expenditure, and commercial expansion of various pharmaceutical companies are driving the growth of this end-user segment.

“North America to dominate the market during the forecast period.”

Geographically, the cell analysis market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the cell analysis market. Factors such as the presence of a favorable business environment, growing government support through funds and grants, growing number of research activities, rising number of drug discovery initiatives by pharmaceutical & biotechnology companies in the US, and the strong presence of key players in this region are driving the growth of the cell analysis market in North America.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type – Tier 1: 36%, Tier 2: 45%, and Tier 3: 19%
• By Designation – C-level: 33%, D-level: 40%, and Others: 27%
• By Region – North America: 35%, Europe: 27%, Asia Pacific: 18%, Latin America: 16%, Middle East and Africa: 4%

Updated Research Report @sdki.jp With Impact Analysis of COVID-19

Hub Motor Market
Rolling Stock Market
Automatic Tire Inflation System Market
Exhaust Heat Recovery System Market

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

List of Companies Profiled in the Report

• Thermo Fisher Scientific (US)
• Danaher Corporation (US)
• Becton, Dickinson and Company (BD) (US)
• GE Healthcare (US)
• Merck KGaA (Germany)
• Agilent Technologies (US)
• Olympus Corporation (Japan)
• Promega Corporation (US)
• PerkinElmer (US)
• Tecan Trading AG (Switzerland)
• Miltenyi Biotec (Germany)
• Carl Zeiss (Germany)
• Bio-Rad Laboratories (US)
• Sysmex Corporation (Japan)
• BioStatus Limited (UK)
• NanoCellect Biomedical (US)
• Cell Biolabs, Inc. (US)
• Creative Bioarray (US)
• Meiji Techno (US)
• Cytek Biosciences, Inc. (US)

Research Coverage:

This report provides a detailed picture of the global cell analysis market. It aims at estimating the size and future growth potential of the market across different segments, such as product, process, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cell analysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, opportunities, and challenges.

Request to fill the form To Get a Sample Copy of This Report: https://www.sdki.jp/sample-request-61940

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:

Shibuya Data Count
Email: [email protected]
Tel: + 81 3 45720790

Categories
News

Cardiac Monitoring and Cardiac Rhythm Management Devices Market Analysis 2020-2024 by Latest Technology, Future Growth, Emerging Trends, Leading Companies, Revenue Analysis

“Increasing prevalence of CVD to drive the growth of this market.” The cardiac monitoring and cardiac rhythm management devices market is projected to reach USD 25.0 billion by 2024 from USD 20.7 billion in 2019, at a CAGR of 3.9%. Growth in this market is primarily driven by the increasing incidence of cardiovascular diseases; technological advancements; increasing investments, funds, and grants for research on CM & CRM devices; and the growing preference for wearable cardiac devices. However, the dearth of skilled professionals and frequent product recalls are expected to challenge market growth in the coming years. CLICK FOR SAMPLE COPY

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

“ILRs are expected to grow at the highest CAGR during the forecast period.”

Based on type, the CM devices market is segmented into ECG devices, ILR, MCT, event monitors, COM devices, and smart ECG monitors. Of these, ILRs are expected to grow at the highest CAGR during the forecast period. The advantages of ILRs are a higher rate of diagnosis of heart rhythm problems than external recorders, long-term monitoring of up to three years, large storage capacity, remote monitoring, and detection & reduction of recurrent syncopes. Owing to their benefits, the demand for these devices is expected to increase across the globe

“The defibrillators segment is expected to grow at the highest CAGR during the forecast period.”

Based on type, the CRM devices market is segmented into defibrillators and pacemakers. The defibrillators segment is expected to grow at the highest CAGR in the forecast period. Technological advancements in defibrillators, rising prevalence of CVDs, and the growing focus on providing public-access defibrillators are some of the major factors expected to propel the growth of this market.

“The ambulatory surgical centers segment is expected to grow at the highest CAGR during the forecast period.”

The ambulatory surgical centers segment is expected to grow at the highest CAGR in the forecast period. Growing number of ASCs and physicians are realizing the benefits of performing cardiovascular procedures at ASCs, thus attributing to its high CAGR during the forecast period.

“APAC to grow at the highest CAGR during the forecast period.”

In the CM & CRM devices market, the APAC market, particularly in China, Japan, India, and the Association of Southeast Asian Nations (ASEAN) countries, is expected to witness the highest growth in the next five years. This is due to the rising prevalence of CVDs in APAC countries, attributed to the increasing adoption of sedentary lifestyles, changing diets, increasing stress, and habitual smoking and drinking.

Updated Research Report @sdki.jp With Impact Analysis of COVID-19

Air Brake System Market
Automotive Simulation Market
Automotive Bushing Market
Automotive Smart Antenna Market

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the CM & CRM devices market.

By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%
By Designation: C-level Executives: 27%, Directors: 18%, and Others: 55%
By Region: North America: 50%, Europe: 20%, APAC: 15%, and RoW: 15%

The CM & CRM devices market comprises major players such as Medtronic (Ireland), Boston Scientific (US), Abbott Laboratories (US), GE Healthcare (US), BIOTRONIK (Germany), Hill-Rom Holdings (US), and Koninklijke Philips (Netherlands). The study includes an in-depth competitive analysis of these key players in the CM & CRM devices market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:

The market study covers the CM & CRM devices market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, based on CM devices by type, and based on CRM devices by type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall CM & CRM devices market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, opportunities, and challenges.

Request to fill the form To Get a Sample Copy of This Report: https://www.sdki.jp/sample-request-61943

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:

Shibuya Data Count
Email: [email protected]
Tel: + 81 3 45720790

Categories
News

ATP Assay Market Analysis 2020-2024 By Leading Companies, Impact of COVID-19 on Growth, Latest Technology, Future Demand Forecast, Applications, End-Users

The global ATP assays market is projected to reach USD 315 million by 2024 from USD 191 million in 2019, at a CAGR of 10.5%. Growth in this market is majorly driven by the increasing demand for ATP assays in pharmaceutical and biotechnology companies, rising investments in pharmaceutical and biotechnology R&D, increasing prevalence of cancer and other chronic and infectious diseases, and shift from culture-based tests to rapid tests.

Request to fill the form To Get a Sample Copy of This Report: https://www.sdki.jp/sample-request-61945

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

The consumables & accessories segment will register the highest growth in the market, by product

Based on product, the market is segmented into consumables & accessories and instruments. The consumables & accessories segment is expected to witness the highest CAGR in the ATP assays market during the forecast period. The large share of this segment can be attributed to the high usage of ATP assays for microbial contamination testing and the growing applications of ATP assays in different industries like food & beverage and agriculture. Their high usage and the need for repeat purchases equate to a larger market share and higher growth rate.

Contamination testing is the largest application segment of the ATP assays industry

Based on application, the market is segmented into contamination testing, disease testing, and drug discovery & development. In 2018, the contamination testing segment accounted for the largest share of the ATP assays market. This is attributed to the high frequency of contamination testing protocols carried out by pharmaceutical & biotechnology companies, the food & beverage industry, and hospitals & diagnostic laboratories, among other end users.

North America will continue to dominate the ATP assays market during the forecast period

By region, the market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the ATP assays market. The large share of North America can be attributed to the rising incidence and prevalence of chronic and infectious diseases, rising demand for cell-based assays in research, increasing focus on cell-based therapeutics, favorable government support for research, and the presence of high-quality infrastructure for clinical & laboratory research in the region.

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

Updated Research Report @sdki.jp With Impact Analysis of COVID-19

Automotive Software Market
Mining Equipment Market
Multi Domain Controller Market
High Voltage Battery Market

The breakup of primary participants is as mentioned below:
• By Company Type: Tier 1: 50%; Tier 2: 10%; and Tier 3: 40%
• By Designation: C-level: 35%; Director-level: 25%; and Others: 40%
• By Region: North America: 40%; Europe: 20%; Asia Pacific: 25%; Latin America: 10%; and the Middle East & Africa: 5%

The prominent players in the global ATP assays market are Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (US), PerkinElmer, Inc. (US), Lonza Group (Switzerland), Promega Corporation (US), Agilent Technologies, Inc. (US), Abcam plc. (UK), Danaher Corporation (US), Hygiena, LLC. (US), BioThema AB (Sweden), Abnova Corporation (Taiwan), AAT Bioquest (US), PromoCell GmbH (Germany), BioVision, Inc. (US), Geno Technology, Inc. (US), Biotium (US), Canvax Biotech S.L. (Spain), Creative Bioarray (US), Elabscience (US) and MBL International Corporation (US).

Research Coverage:

The report analyzes the ATP assays market and aims at estimating the market size and future growth potential of this market based on various segments such as product, application, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights into:

• Market Penetration: Comprehensive information on the product portfolios of the top players in the ATP assays market. The report analyzes this market by product, application, end user, and region.
• Market Development: Comprehensive information on the lucrative emerging markets by product, application, end user, and region.
• Market Diversification: Exhaustive information about products, growing geographies, recent developments, and investments in the ATP assays market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players in the ATP assays market.

Request to fill the form To Get a Sample Copy of This Report: https://www.sdki.jp/sample-request-61945

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:

Shibuya Data Count
Email: [email protected]
Tel: + 81 3 45720790

Categories
News

Anatomic Pathology Market Analysis 2020-2024 By Latest Technology, Growth Opportunities, Emerging Trends, Leading Companies, Impact of COVID-19 on Demand

“High incidence of cancer & other target diseases, availability of reimbursement, and the growing focus on personalized medicine are driving the overall growth of the anatomic pathology market” The anatomic pathology market is projected to reach a value of USD 44.4 billion by 2024 from USD 33.0 billion in 2019, at a CAGR of 6.1% during the forecast period. The growth in this market is attributed to the high incidence of cancer and other target diseases, availability of reimbursement, and the growing focus on personalized medicine. In addition, emerging economies such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the anatomic pathology market during the forecast period. However, the availability of refurbished products, the lack of skilled professionals, and product recalls are expected to hamper market growth to a certain extent in the coming years.

Request to fill the form To Get a Sample Copy of This Report: https://www.sdki.jp/sample-request-61948

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

“Disease diagnosis segment accounted for the larger share of the anatomic pathology market, by application, in 2018”

Based on application, the anatomic pathology market is segmented into disease diagnosis and medical research. In 2018, the disease diagnosis segment accounted for the larger market share, due to the rapid growth in the geriatric population and the increasing incidence of cancer and other chronic diseases.

“Hospital laboratories to register the highest growth in the anatomic pathology market during the forecast period”

Based on end user, the anatomic pathology market is segmented into clinical laboratories, hospital laboratories, and other end users. The hospital laboratories segment accounted for the largest market share in 2018 and is projected to register the highest CAGR during the forecast period. The growth of this segment can be attributed to the increasing number of patient visits to hospitals, growing number of in-house diagnostic procedures performed in hospitals, growing awareness regarding early disease diagnosis, and the availability of reimbursements in developed markets for clinical tests performed in hospitals.

“North America will continue to dominate the anatomic pathology market during the forecast period”

Geographically, the anatomic pathology market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2018, North America accounted for the largest market share, followed by Europe. Factors such as the rising prevalence of chronic diseases, increasing healthcare expenditure, the high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the anatomic pathology market in North America.

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

Updated Research Report @sdki.jp With Impact Analysis of COVID-19

Automotive Piston Pin Market
Body Control Module Market
HD Map for Autonomous Vehicles Market
EV Connectors Market

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 36%, Tier 2 – 45%, and Tier 3 – 19%
• By Designation: C-level – 33%, D-level – 40%, and Others – 27%
• By Region: North America – 36%, Europe – 28%, Asia Pacific – 19%, and the Rest of the World – 17%

List of Companies Profiled in the Report

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Danaher Corporation (US)
• Thermo Fisher Scientific (US)
• Hologic, Inc. (US)
• Agilent Technologies (US)
• Becton, Dickinson and Company (US)
• Sakura Finetek (Japan)
• Merck KGaA (Germany)
• Bio SB (US)
• Diapath S.p.A. (Italy)
• BioGenex Laboratories (US)
• Abcam (US)
• Milestone Medical (Italy)
• SLEE medical (Germany)
• Histo-Line Laboratories (Italy)
• Amos Scientific (Australia)
• Jinhua YIDI Medical Appliance Co. Ltd. (China)
• MEDITE GmbH (Germany)
• Cell Signaling Technology (US)
• CellPath (UK)

Research Coverage:

This report provides a detailed picture of the global anatomic pathology market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall anatomic pathology market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, challenges, opportunities, and trends.

Request to fill the form To Get a Sample Copy of This Report: https://www.sdki.jp/sample-request-61948

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:

Shibuya Data Count
Email: [email protected]
Tel: + 81 3 45720790

Categories
News

Healthcare IT Integration (HCIT) Market Analysis 2020-2024 by Latest Technology, Top 10 Companies, Future Growth Opportunities, Emerging Trends, Impact of COVID-19

The global healthcare IT integration solutions market is projected to reach USD 5.3 billion by 2024 from USD 3.1 billion in 2019, at a CAGR of 10.9% during the forecast period. The market for HCIT integration solutions is primarily driven by the increasing need for integration owing to the rising healthcare costs and the growing volume of data generated in healthcare systems. The need to improve patient safety and the favorable government and private support for HCIT will also contribute to market growth. However, the high costs of HCIT integration will hinder the overall adoption of solutions and thereby restrain market growth in the coming years.

Request to fill the form To Get a Sample Copy of This Report: https://www.sdki.jp/sample-request-61973

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

“In 2018, the interface/integration engines segment accounted for the largest share of the market.”

On the basis of type, the interface/integration engines segment accounted for the largest share of the healthcare IT integration products market in 2018. The large share of this segment can be attributed to the increasing need for information exchange within healthcare service provider facilities or with other affiliated organizations. Furthermore, the emergence of health information exchange (HIE) backed by government initiatives to promote integrated healthcare infrastructure also support the growth of this market.

“In 2018, the support & maintenance services segment accounted for the largest share of the market.”

On the basis of type, the support & maintenance services segment accounted for the largest share of the healthcare IT integration services market in 2018. Healthcare providers prefer outsourcing their healthcare IT support & maintenance needs to either healthcare IT integration solution vendors or third-party support & maintenance service providers to focus on their core business areas.

“APAC is projected to witness the highest growth during the forecast period.”

The APAC market is estimated to register the highest CAGR during the forecast period. The growth in this market can be attributed to the presence of less-stringent regulations, increasing demand for quality healthcare at low costs, and improving healthcare infrastructure in several APAC countries.

The breakdown of primary participants was as mentioned below:
• By Company Type: Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation: C-level–40%, Director Level–35%, and Others–25%
• By Region: North America–35%, Europe–28%, Asia Pacific–20%, Latin America–10%, Middle East & Africa–7%

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

Updated Research Report @sdki.jp With Impact Analysis of COVID-19

Modular Trailer Market
Fluid Transfer System Market
Highway Driving Assist Market
Military Truck Market

The leading players in this market include Infor (US), InterSystems Corporation (US), Cerner Corporation (US), Orion Health (New Zealand), NextGen Healthcare Inc. (US), iNTERFACEWARE, Inc. (Canada), Allscripts Healthcare Solutions, Inc. (US), Epic Systems Corporation (US), AVI-SPL, Inc. (US), Corepoint Health (US), and MEDITECH (US).

Research Coverage:

The report analyzes the various healthcare IT integration solutions and their adoption pattern. It aims at estimating the market size and future growth potential of the healthcare IT integration solutions market for different segments such as product & service, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the healthcare IT integration solutions market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the healthcare IT integration solutions market
• Market Development: Comprehensive information on the lucrative emerging regions by product & service, end user, and region
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the healthcare IT integration solutions market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the healthcare IT integration solutions market

Request to fill the form To Get a Sample Copy of This Report: https://www.sdki.jp/sample-request-61973

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:

Shibuya Data Count
Email: [email protected]
Tel: + 81 3 45720790

Categories
News

By Registering A CAGR of 6.7%, Mass Spectrometry Market Is Projected To Reach USD 6.3 Billion During Forecast Period 2020-2024

The mass spectrometry market is projected to reach USD 6.3 billion by 2024 from USD 4.6 billion in 2019 at a CAGR of 6.7%. The technological advancements in mass spectrometers is driving the growth of the market. Government initiatives for pollution control and environmental testing, increasing spending on pharmaceutical R&D across the globe, government regulations on drug safety, growing focus on the quality of food products, and increase in crude and shale gas production are also supporting the growth of this market. However, the dearth of skilled professionals and the high cost of instruments may restrain the market to a certain extent during the forecast period.

Request to fill the form To Get a Sample Copy of This Report: https://www.sdki.jp/sample-request-61982

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

“The hybrid mass spectrometry segment is projected to dominate the mass spectrometry products market during the forecast period.”

The mass spectrometry products market has been segmented into hybrid mass spectrometry, single mass spectrometry, and other platforms. The hybrid mass spectrometry segment further includes triple quadrupole, quadrupole TOF, and Fourier transform mass spectrometry devices, while the single mass spectrometry segment includes single quadrupole, Time of Flight (TOF), and ion trap spectrometers. The hybrid mass spectrometry segment held the largest share of this market in 2018 and is also estimated to grow at the highest CAGR during the forecast period. Hybrid mass spectrometers are technologically enhanced instruments that comprise a combination of two mass spectrometry platforms as compared to a single platform in single MS and hence provide higher accuracy, sensitivity, and efficiency in testing.

“The pharmaceutical & biotechnology applications segment held the largest market share in 2018.”

By application, the mass spectrometry market is segmented into pharmaceutical & biotechnology applications, environmental testing, food & beverage testing, petrochemical applications, and other applications. The pharmaceutical & biotechnology applications segment accounted for the largest share of this market in 2018. The large share of this segment can be attributed to the growing research in proteomics and metabolomics and the rise in demand for pharmaceutical biosimilars, phytopharmaceuticals, and regenerative medicine.

“The North American mass spectrometry market is expected to hold the largest market during the forecast period.”

Geographically, the mass spectrometry market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The North American market is expected to hold the largest share of this market during the forecast period. The growing funding for research and government initiatives in the US, widespread usage of mass spectrometry in the metabolomics and petroleum sector, and CFI funding towards mass spectrometry projects in Canada are the key factors driving the North American mass spectrometry market.

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

Automotive Seats Market
Automotive Actuators Market
Ride Sharing Market
Automotive Lighting Market

Breakdown of supply-side primary interviews:

• By Company Type: Tier 1 – 50%, Tier 2 – 30%, and Tier 3 – 20%
• By Designation: C-level – 37%, Director-level – 29%, and Others – 34%
• By Region: North America – 30%, Europe – 33%, APAC – 27%, and RoW – 10%

The major players in the market include SCIEX (US), Agilent Technologies (US), Thermo Fisher Scientific (US), Waters Corporation (US), PerkinElmer (US), Shimadzu Corporation (Japan), Bruker (US), Analytik Jena (Germany), JEOL (Japan), Rigaku (Japan), DANI Instruments (Italy), LECO (US), Hiden Analytical (UK), Kore Technology (UK), Extrel CMS (US), MassTech (US), AMETEK Process Instruments (US), MKS Instruments (US), Advion (US), and FLIR Systems (US).

Research Coverage

This report studies the mass spectrometry market based on product, application, end-user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning their growth trends and forecasts the revenue of the market segments for four main regions and respective countries.

Key Benefits of Buying the Report

This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the mass spectrometry market, and high-growth regions with their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

Request to fill the form To Get a Sample Copy of This Report: https://www.sdki.jp/sample-request-61982

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:

Shibuya Data Count
Email: [email protected]
Tel: + 81 3 45720790

Categories
News

Carrier Screening Market Is Expected To Driven By Increasing Emphasis on Early Disease Detection and Prevention (Projected To Register A CAGR of 17.5% Till 2024)

The global carrier screening market size is expected to grow from USD 1.8 billion in 2019 to USD 4.0 billion by 2024, at a CAGR of 17.5% during the forecast period. Growth in the carrier screening market can primarily be attributed to factors such as increasing emphasis on early disease detection and prevention, the high risk of chromosomal abnormalities, and technological advancements in carrier screening, such as the introduction of expanded carrier screening panels. The increasing awareness of carrier screening is expected to provide a wide range of growth opportunities for players in the market.

Request to fill the form To Get a Sample Copy of This Report: https://www.sdki.jp/sample-request-61988

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

“The expanded carrier screening segment is expected to grow at the highest CAGR during the forecast period.”

On the basis of type, the carrier screening market is segmented into targeted disease screening and expanded carrier screening, which includes predesigned and customized carrier screening panel testing. The growth of this segment can be attributed to factors such as the increasing use of new high-throughput technologies such as sequencing & microarrays and recommendations for the use of expanded carrier screening.

“In 2018, the hospitals segment accounted for the largest share of the carrier screening market.”

On the basis of end user, the carrier screening market is segmented into hospitals, physician offices and clinics, reference laboratories, and other end users (blood banks, donor banks, community clinic laboratories, and non-profit organizations). In 2018, hospitals formed the largest end-user segment in the carrier screening market. Generally, gynecologists suggest couples to undergo carrier screening tests before and after pregnancy. In such cases, it is observed that gynecologists give reference for genetic counselors, who generally practice at hospitals. As a result, the awareness about hospital-based carrier screening tests is higher among patients than those offered at reference laboratories or at physician offices and clinics. Also, hospitals offer flexibility to patients in terms of sample collection, scheduling specimen pickups, and rapid turnaround time to produce results.

“North America to grow at the highest CAGR during the forecast period.”

North America is expected to grow at the highest rate during the forecast period, followed by Europe. This growth can be attributed to several factors, such as the presence of well-established healthcare systems in the US and Canada, wide access to advanced screening techniques (such as DNA sequencing), recommendations for carrier screening, high and growing demand for the early detection of genetic disorders among the population, availability of mass genetic testing programs, increasing number of awareness campaigns, and the high incidence of chromosomal disorders.

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

Updated Research Report @sdki.jp With Impact Analysis of COVID-19

Side View Camera System Market
Automotive Cybersecurity Market
Automotive Interior Market
Automotive Heat Shield Market

In-depth interviews were conducted with chief executive officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the carrier screening market.

By Respondent Type: Supply-side: 80%, Demand-side: 20%
By Designation: C-level Executives: 27%, Directors: 18%, and Others: 55%
By Region: North America: 50%, Europe: 20%, APAC: 15%, and RoW: 15%

The carrier screening market comprises major players such as Illumina (US), Natera (US), Fulgent Genetics (US), Sema4 (US), Invitae (US), and LabCorp (US). The study includes an in-depth competitive analysis of these key players in the market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:

The market study covers the carrier screening market across various segments. It aims at estimating the market size and the growth potential of this market across different segments based on the product & service, medical conditions, technology, condition, type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall carrier screening market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, opportunities, and challenges.

Request to fill the form To Get a Sample Copy of This Report: https://www.sdki.jp/sample-request-61988

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:

Shibuya Data Count
Email: [email protected]
Tel: + 81 3 45720790

Categories
News

Animal Genetics Market Analysis 2020-2023 By Product and Services, Leading Companies, Latest Technology, End-Use

The global animal genetics market is projected to reach USD 5.8 billion by 2023 from USD 4.2 billion in 2018, at a CAGR of 6.5 % during the forecast period. Factors such as rising consumption for animal-derived protein, growing population and rapid urbanization across the globe, increased adoption of genetic services and advanced genetic technologies for larger-scale production and quality breeds, and growing focus on identifying superior breeds are likely to boost the growth of the market. However, shortage of skilled professionals in veterinary research and technicians for performing advanced genetic services is a major factor restraining the growth of this market.

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-61745

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”

“By product & service, animal genetics products market is expected to hold the largest market share in 2018”
The animal genetics products segment is expected to dominate the animal genetics market during the forecast period. This is primarily attributed to the high global demand for live animals generated by farmers and animal breeders, as well as the animal food industry, and the high adoption of genetic materials by breeders to carry out large- scale artificial insemination and embryo transfer practices. This is primarily triggered by the growing global demand for animal protein, growing population and rapid urbanization in the emerging countries. Besides, technological advancements pertaining to the application of various biotechnology approaches for genetic material transfer such as semen sexing, artificial insemination, and in vitro fertilization are also contributing to the growth of this market.

“By services, the genetic disease tests market is expected to hold the largest share in 2018”
The genetic disease tests segment is expected to dominate the animal genetics market. This can be attributed to the increasing adoption of these tests by animal breeders and owners to prevent economic losses and loss of productivity caused due to the incidence of the genetic diseases in animals. Genetically inherited infectious diseases in farm animals are a major concern because of the production costs and the possible consequences to public health. Infected breeds in farms can lead to multiplication of the infection, if not tested before breeding. This can lead to huge economic losses to the farm. The cost of infections in farm animals is mainly the opportunity cost arising from production losses, as infected animals can reduce average farm productivity drastically.

“North America is expected to hold the largest share during the forecast period (2018–2023)”
North America is expected to dominate the animal genetics market during the forecast period. This is attributed to the better accessibility to advanced genomic technologies and well-established distribution channels across the region. Besides, the presence of prominent livestock sector, and a number of leading players in this region, along with the growing demand for animal food products is also expected to propel the growth in this region.

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”

Updated Research Report @sdki.jp With Impact Analysis of COVID-19

Electric Bus Market
Electric Commercial Vehicle Market
Automotive Turbocharger Market
Mining Machinery Market

Break of supply side primary participants was as mentioned below:
• By Company Type – Tier 1–55%, Tier 2–20% and Tier 3–25%
• By Designation – C-level–35%, Director Level–25%, Others–40%
• By Region –North America–45%, Europe–30%, Asia-Pacific–20%, Middle East & Africa–3%, Latin America – 2%

The prominent players in the animal genetics market are Neogen Corporation (US), Genus (UK), URUS (US), EW Group (Germany), Groupe Grimaud (France), CRV Holding (Netherlands), Topigs Norsvin (Netherlands), Zoetis (US), Envigo (US), Hendrix Genetics (Netherlands), Animal Genetics (US), and vetGen (US).

Research Coverage:
The animal genetics market in this report is segmented by product & service, and regions. It provides detailed information regarding major factors influencing the growth market (drivers, restraints, opportunities, and industry-specific challenges). The study tracks and analyzes competitive developments (such as partnerships, agreements, collaborations, mergers & acquisitions, product developments, geographical expansions, and R&D activities) and strategically profiles the key players and comprehensively analyzes their market ranks and core competencies in the animal genetics market.

Reasons to buy this report:
From an insight perspective, this research report has focused on various levels of analysis—market share analysis of top players, company profiles which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the animal genetics market; high-growth regions; and market drivers, restraints, and opportunities. The report provides the latest statistics and industry trends, allowing buyers to identify the high growth product segment and potential customers and suppliers hence driving revenue growth and profitability.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on animal genetic products and services offered by the top players in the global animal genetics market

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the global animal genetics market

• Market Development: Comprehensive information about lucrative emerging markets–the report analyzes the markets for global animal genetics market across regions

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global animal genetics market

• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global animal genetics market

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-61745

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:

Shibuya Data Count
Email: [email protected]
Tel: + 81 3 45720790